VDR Gene and Vitamin D: Personalizing Your Sunshine Vitamin Intake

Vitamin D occupies a unique position in human nutrition: it's the only vitamin we can synthesise from sunlight, yet vitamin D deficiency is the most common nutritional deficiency globally, affecting an estimated 1 billion people. And even among people with identical sun exposure and dietary intake, vitamin D status varies dramatically. A large part of this variability traces back to a single gene: VDR, the vitamin D receptor gene.

Understanding your VDR genotype is one of the most actionable genetic insights in nutrition, because vitamin D's effects span bone health, immune function, cancer prevention, cardiovascular health, mental health, and more, and because the optimal supplementation dose varies substantially by genotype.

Vitamin D: From Sunshine to Active Hormone

Despite being called a "vitamin," vitamin D functions as a hormone. Its synthesis and activation require multiple steps:

1. Skin synthesis: UVB radiation (290-315nm) converts 7-dehydrocholesterol in skin to pre-vitamin D3, which isomerises to cholecalciferol (vitamin D3)
2. First liver hydroxylation: 25-hydroxylase (CYP2R1) converts D3 to 25-hydroxyvitamin D (25-OH-D), the form measured by blood tests
3. Second kidney hydroxylation: 1α-hydroxylase (CYP27B1) converts 25-OH-D to 1,25-dihydroxyvitamin D (calcitriol), the biologically active form
4. Receptor binding: Calcitriol binds to the Vitamin D Receptor (VDR), a nuclear receptor that regulates the expression of hundreds of genes

VDR variants influence the final, and in many ways most important, step: how effectively the active vitamin D signal is received and translated into gene expression.

Key VDR Polymorphisms

FokI (rs2228570), Receptor Length and Signalling Efficiency

This variant in the translation initiation site creates two different lengths of VDR protein:

• FF genotype (short, "start" form): The shorter VDR protein is more efficient, it interacts more powerfully with transcription factors, producing stronger signalling per molecule of calcitriol. Generally associated with better bone mineral density and immune function at a given vitamin D level.
• Ff or ff genotype (long form): The longer VDR is less transcriptionally efficient. Individuals with the ff genotype typically need higher vitamin D levels to achieve equivalent biological effects.

BsmI, ApaI, TaqI (BAt haplotype)

These three polymorphisms in intron 8 are in strong linkage disequilibrium (they tend to be inherited together). Their combined effect influences VDR mRNA stability and expression level:

• The bb combination: associated with lower VDR expression, reduced calcium absorption efficiency, and greater vitamin D "need" to achieve target outcomes
• The BB combination: associated with higher VDR expression and more efficient vitamin D signalling

Cdx2 (rs11568820)

Located in the VDR promoter region, this variant affects intestinal VDR expression specifically, influencing the vitamin D-dependent absorption of calcium and phosphate in the gut.

What VDR Variants Affect

Bone Health and Calcium Absorption

Vitamin D's canonical role is supporting calcium absorption from the gut. VDR-mediated gene expression in intestinal cells determines how efficiently dietary calcium is absorbed. Individuals with low-activity VDR variants have reduced calcium absorption per unit of vitamin D, requiring either higher vitamin D levels or higher dietary calcium to achieve equivalent bone mineralisation.

Meta-analyses of VDR variants and bone mineral density consistently show that VDR genotype is an independent predictor of osteoporosis risk, with the effect size comparable to known dietary and lifestyle risk factors.

Immune Function and Infection Resistance

VDR is expressed in virtually all immune cells. Vitamin D/VDR signalling:

• Induces production of antimicrobial peptides (cathelicidins and defensins), natural antibiotics produced by immune cells
• Modulates T-cell differentiation, shifting immune balance toward anti-inflammatory regulatory T cells
• Enhances macrophage function against intracellular pathogens

VDR variants have been associated with susceptibility to tuberculosis, respiratory infections (including influenza and COVID-19), autoimmune diseases (multiple sclerosis, type 1 diabetes, rheumatoid arthritis), and inflammatory bowel disease in multiple population studies.

Individuals with low-activity VDR variants who also have vitamin D deficiency may have substantially impaired immune function, a compounding vulnerability that is entirely addressable through supplementation.

Cancer Prevention

VDR-mediated pathways regulate cell proliferation, differentiation, and apoptosis. Adequate vitamin D/VDR signalling appears to suppress tumour development in multiple tissue types. Meta-analyses support associations between VDR variants and risk of colorectal, breast, prostate, and skin cancers. Higher circulating 25-OH-D levels (>75 nmol/L) are consistently associated with reduced cancer incidence in observational studies.

Mental Health

VDR is highly expressed in brain regions involved in mood regulation including the hippocampus, prefrontal cortex, and hypothalamus. Vitamin D/VDR signalling modulates serotonin synthesis and release. VDR variants have been associated with depression risk in some studies, and randomised trials of vitamin D supplementation in deficient individuals show modest but consistent improvements in depression scores.

Cardiovascular and Metabolic Health

VDR variants influence insulin secretion, pancreatic beta-cell function, and cardiomyocyte physiology. Low vitamin D/VDR signalling has been linked to insulin resistance, type 2 diabetes incidence, and hypertension. Whether supplementation causally improves these outcomes is debated, but epidemiological associations with low vitamin D are robust.

Sun Exposure and Skin Synthesis: Individual Variation

Beyond VDR, additional genetic factors influence vitamin D production from sunlight:

CYP2R1 and GC (DBP)

• CYP2R1 variants affect the efficiency of the liver's first hydroxylation step, some individuals convert D3 to 25-OH-D less efficiently
• GC gene encodes vitamin D binding protein (DBP), which transports 25-OH-D in blood. GC variants affect how much "free" active vitamin D is available versus bound, with significant implications for actual bioavailability

Melanin and Latitude

Higher melanin content (darker skin) reduces UVB penetration, requiring longer sun exposure to synthesise equivalent D3. At northern latitudes (above 40°N), UVB intensity is insufficient for D3 synthesis during winter months regardless of skin type, making dietary and supplemental sources the only option for 4-6 months of the year.

Optimising Vitamin D Status

Target Blood Levels

• Deficient: Below 25 nmol/L (10 ng/mL), associated with rickets, osteomalacia, severe immune impairment
• Insufficient: 25-50 nmol/L (10-20 ng/mL), common in Northern European winter months
• Sufficient (general): 50-75 nmol/L (20-30 ng/mL)
• Optimal (evidence-supported): 75-150 nmol/L (30-60 ng/mL), for bone, immune, and potential cancer prevention benefits
• Low-activity VDR carriers: Target the higher end of the optimal range, 100-150 nmol/L, to compensate for reduced signalling efficiency

Food Sources

• Oily fish: Salmon (447-600 IU per 100g), sardines (272 IU), mackerel, herring
• Cod liver oil: ~1,360 IU per tablespoon, one of the most concentrated food sources
• Egg yolks: Approximately 44 IU per yolk (from pasture-raised hens, up to 4× more)
• UV-exposed mushrooms: Mushrooms exposed to UV light can produce meaningful D2; some brands are specifically UV-treated
• Fortified foods: Many milks, plant milks, and cereals are D3-fortified

Food alone is typically insufficient to achieve optimal vitamin D levels, particularly at northern latitudes in winter or for individuals with low-activity VDR variants. Supplementation is almost universally recommended above 50° latitude from October to March.

Supplementation Recommendations

• General adult maintenance (VDR normal): 1,000-2,000 IU D3/day during winter
• Low-activity VDR variants or confirmed insufficiency: 2,000-4,000 IU D3/day; retest after 3 months
• Confirmed deficiency: Loading doses (up to 10,000 IU/day for 4-8 weeks) under medical supervision, followed by maintenance
• Form: D3 (cholecalciferol) is significantly more effective than D2 (ergocalciferol) at raising serum 25-OH-D
• Co-factors: Take with vitamin K2 (MK-7 form, 100-200 mcg/day) to direct calcium to bones rather than arteries; magnesium (D metabolism requires magnesium)

Key Takeaways

• VDR variants determine the efficiency of vitamin D signalling, individuals with low-activity variants need higher circulating 25-OH-D to achieve equivalent biological effects
• Vitamin D's role extends far beyond bone health, VDR signalling influences immunity, cancer prevention, mental health, and metabolic function
• Target 75-150 nmol/L for optimal outcomes; low-activity VDR carriers should target the upper part of this range
• D3 supplementation is almost universally needed above 50° latitude in winter, and for those with limited sun exposure year-round
• Take vitamin D3 with K2 (MK-7) and ensure adequate magnesium, these co-factors determine how effectively supplemental D is utilised

Scientific References

Key references include Uitterlinden et al. (2004) on VDR variants and osteoporosis risk, Holick (2007) on Vitamin D deficiency in the New England Journal of Medicine, and the VITAL trial (Manson et al., 2019) for supplementation effects. The VDR-immune system connection is reviewed comprehensively by Aranow (2011) in the Journal of Investigative Medicine.